Business Services
Pharmaceutical Business Services – News, analysis and company profiles
Eli Lilly to acquire Sigilon Therapeutics
June 30, 2023 Business Services Chronic Diseases, Eli Lilly, Sigilon, acquisition
Zymeworks to open new EU HQ in Dublin, Ireland
June 22, 2023 Business Services Dublin, Oncology, Zymeworks, headquarters, regulatory affiars
Eli Lilly to acquire DICE Therapeutics for immunology innovations
June 21, 2023 Business Services DICE Therapeutics, Eli Lilly, Immunology, acquisition, immunology
AstraZeneca’s breast cancer drug given Priority Review by FDA
June 13, 2023 Business Services AstraZeneca, FDA, Oncology, breast cancer
Inizio launches strategic engagement offering to transform customer experiences
June 7, 2023 Business Services Inizio, Inizio Engage, commercialisation
FlyPharma Europe, Vienna: the early bird deal for FlyPharma Vienna closes on 24 May
May 9, 2023 Business Services, Conferences Conference, flypharma
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
April 27, 2023 Business Services CHMP, Cosentyx, Dermatology, Novartis
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
April 26, 2023 Business Services
Epsilogen announces significant expansion of management team with three new senior hires
April 26, 2023 Business Services
Real-world data analysis shows significant improvement in glycaemic management when using a blood glucose monitor connected to the mySugr® app in UK users with type 2 diabetes
April 26, 2023 Business Services
MiNA Therapeutics Enters Research Collaboration with BioMarin Pharmaceutical to Advance RNAa Platform Research in Rare Genetic Diseases
April 25, 2023 Business Services
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
April 25, 2023 Business Services
Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership
April 25, 2023 Business Services
Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference
April 25, 2023 Business Services
National Institute for Health and Care Excellence recommends Darzalex® (daratumumab) with bortezomib and dexamethasone for routine use on the NHS as treatment for multiple myeloma
April 24, 2023 Business Services
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
